Upgrade to SI Premium - Free Trial

Protagonist Therapeutics (PTGX) PT Raised to $170 at H.C. Wainwright

September 1, 2026 7:13 AM
(Updated - September 1, 2026 7:15 AM EDT)

H.C. Wainwright analyst Douglas Tsao raised the price target on Protagonist ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change